These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4838694)

  • 1. The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia.
    Kissebah AH; Adams PW; Harrigan P; Wynn V
    Eur J Clin Invest; 1974 Jun; 4(3):163-74. PubMed ID: 4838694
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypolipemic agents].
    Paoletti R; Fumagalli R; Sirtori R
    Minerva Med; 1973 Apr; 64(24):1267-75. PubMed ID: 4707410
    [No Abstract]   [Full Text] [Related]  

  • 3. Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver.
    Barter PJ; Nestel PJ; Carroll KF
    Metabolism; 1972 Feb; 21(2):117-24. PubMed ID: 5009387
    [No Abstract]   [Full Text] [Related]  

  • 4. The kinetics of plasma free fatty acid and triglyceride transport in patients with idiopathic hypertriglyceridaemia and their relation to carbohydrate metabolism.
    Adams PW; Kissebah AH; Harrigan P; Stokes T; Wynn V
    Eur J Clin Invest; 1974 Jun; 4(3):149-61. PubMed ID: 4838693
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats.
    Priego JG; Maroto ML; Piña M; Catalán RE
    Gen Pharmacol; 1979; 10(4):315-8. PubMed ID: 488666
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of drugs on plasma triglyceride metabolism.
    Nikkila EA
    Adv Exp Med Biol; 1972; 26(0):113-33. PubMed ID: 4606489
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.
    Wolfe BM; Kane JP; Havel RJ; Brewster HP
    J Clin Invest; 1973 Sep; 52(9):2146-59. PubMed ID: 4353773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis.
    Schlierf G; Dorow E
    J Clin Invest; 1973 Mar; 52(3):732-40. PubMed ID: 4685092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
    Singer P; Gnauck G; Honigmann G; Thoelke H; Schliack V; Läuter J
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(1):27-37. PubMed ID: 913315
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of nicotinic acid on the diurnal variation of the free fatty acids of plasma.
    Carlström S; Laurell S
    Acta Med Scand; 1968; 184(1-2):121-3. PubMed ID: 5317782
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of clofibrate treatment on arginine-induced insulin secretion in endogenous hypertriglyceridemia.
    Fedele D; Tiengo A; Muggeo M; Nosadini R; Crepaldi G
    Atherosclerosis; 1976; 25(2-3):191-8. PubMed ID: 1008908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats.
    Cayen MN; Robinson WT; Dubuc J; Dvornik D
    Biochem Pharmacol; 1979 Apr; 28(7):1163-7. PubMed ID: 444274
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of intravenously administered fructose and glucose on splanchnic secretion of plasma triglycerides in hypertriglyceridemic men.
    Wolfe BM; Ahuja SP
    Metabolism; 1977 Sep; 26(9):963-78. PubMed ID: 197378
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a combination of propranolol and nicotinic acid on the inhibition of norepinephrine-induced elevations of serum triglyceride, serum glycerol, and plasma free fatty acids in the dog.
    Lipson MJ; Naimi S; Proger S
    Metabolism; 1971 Jun; 20(6):580-9. PubMed ID: 5578972
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of heparin infusion on plasma triglyceride in vivo and in vitro with a method for calculating triglyceride turnover.
    Porte D; Bierman EL
    J Lab Clin Med; 1969 Apr; 73(4):631-48. PubMed ID: 5775134
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol.
    Vessby B; Lithell H; Gustafsson IB; Boberg J
    Atherosclerosis; 1980 Jan; 35(1):51-65. PubMed ID: 6989377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperlipiemia and its therapy by clofibrate].
    Nakano M; Nakamura Y
    Iryo; 1969 Dec; 23(12):1473-8. PubMed ID: 5381198
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the mechanism of inhibition of acute alcoholic fatty liver by clofibrate.
    Kähönen MT; Yilkahri RH; Hassinen I
    Metabolism; 1972 Nov; 21(11):1021-8. PubMed ID: 5080087
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
    Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
    Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
    Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
    Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.